Home › Alzheimer's Disease › Ohio
Alzheimer's Disease clinical trials in Ohio
17 studies for Alzheimer's Disease are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Dayton
- Clinical Site, Independence
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2617, Blue Ash
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Local Institution - 1265, Cleveland
- Ohio State University, Columbus
- Local Institution - 1258, Dayton
- and 1 more
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- NDx Clinical Research, Dayton
RecruitingPhase 2
Ages 55 to 80 · All sexes · Updated Sep 21, 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Ohio State University, Columbus
RecruitingPhase 3
Ages 50 to 90 · All sexes · Updated Sep 21, 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Velocity Clinical Research - Blue Ash, Blue Ash
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Cleveland Clinic, Cleveland
- Local Institution - 0087, Columbus
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Insight Clinical Trials ( Site 1011), Independence
- Neuro-Behavioral Clinical Research ( Site 1028), North Canton
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Aug 26, 2026 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Ohio State University, Columbus
- NDx Clinical Research Inc., Dayton
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- NDx Clinical Research, Inc., Dayton
- Care Access - Lima, Lima
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Jul 7, 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Local Institution - 0029, Cleveland
- Insight Clinical Trials LLC - Independence, Independence
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Jun 30, 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- The Ohio State University, Columbus
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Jun 26, 2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Insight Clinical Trials LLC, Beachwood
- Valley Medical Research, Centerville
RecruitingPhase 3
Ages 50 and older · All sexes · Updated May 22, 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Case Western Reserve University, Beachwood
- University of Cincinnati, Cincinnati
RecruitingObservational study
Ages 25 to 55 · All sexes · Updated May 18, 2026 · NCT04165109Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- Ohio University, Athens
- The Ohio State University, Columbus
Recruiting
Ages 60 and older · All sexes · Updated Mar 5, 2026 · NCT05748613Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- The Ohio State University, Columbus
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 30, 2025 · NCT03019757From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.